Suppr超能文献

急性哮喘住院成人患者口服与静脉注射皮质类固醇的比较。

Oral versus intravenous corticosteroids in adults hospitalised with acute asthma.

作者信息

Cunnington D, Smith N, Steed K, Rosengarten P, Kelly A M, Teichtahl H

机构信息

Department of Respiratory and Sleep Disorders Medicine, Western Hospital, Gordon Street, Footscray, Vic. 3011, Australia.

出版信息

Pulm Pharmacol Ther. 2005;18(3):207-12. doi: 10.1016/j.pupt.2004.12.003. Epub 2005 Jan 24.

Abstract

BACKGROUND

Systemic corticosteroids are routinely used in the management of acute asthma, however the optimum route of administration for patients requiring hospitalisation is unclear. Intravenous (IV) corticosteroids are used in practice, but they may not offer any advantage over oral corticosteroids.

AIM

To compare the efficacy of oral and IV administration of corticosteroids in the treatment of adults hospitalised with acute asthma.

METHOD

Adults admitted to hospital for treatment of acute asthma were randomised to receive oral prednisolone 100 mg once daily or hydrocortisone 100 mg IV 6 hourly for 72 h following admission. All patients concurrently received inhaled corticosteroids and bronchodilators. Improvements in peak expiratory flow rate (PEF) from baseline were compared for 72 h.

RESULTS

Forty-seven patients were randomized, 30 females, 17 males. Twenty-four received oral prednisolone and 23 received IV hydrocortisone. At baseline the oral and IV groups were similar (mean, SD) in age (38.3, 12.8 vs 37.3, 12.9, P=0.80) and initial percent predicted (PP) PEF (61, 16.7 vs 69, 13.0, P=0.11). After 72 h both groups had similar improvements in PEF (27%, 26 vs 27%, 19, P=0.96).

CONCLUSION

Corticosteroids administered orally and IV had similar efficacy in the treatment of adults hospitalised with acute asthma.

摘要

背景

全身用糖皮质激素常用于急性哮喘的治疗,但对于需要住院治疗的患者,最佳给药途径尚不清楚。实际中使用静脉注射(IV)糖皮质激素,但与口服糖皮质激素相比,可能并无优势。

目的

比较口服和静脉注射糖皮质激素治疗急性哮喘住院成人患者的疗效。

方法

因急性哮喘入院治疗的成人患者被随机分为两组,一组每日口服100 mg泼尼松龙,另一组入院后72小时内每6小时静脉注射100 mg氢化可的松。所有患者同时接受吸入性糖皮质激素和支气管扩张剂治疗。比较72小时内两组患者呼气峰值流速(PEF)较基线水平的改善情况。

结果

47例患者被随机分组,其中女性30例,男性17例。24例接受口服泼尼松龙,23例接受静脉注射氢化可的松。基线时口服组和静脉注射组在年龄(38.3, 12.8 vs 37.3, 12.9, P = 0.80)和初始预测百分比(PP)PEF(61, 16.7 vs 69, 13.0, P = 0.11)方面相似。72小时后,两组患者的PEF改善情况相似(27%, 26 vs 27%, 19, P = 0.96)。

结论

口服和静脉注射糖皮质激素治疗急性哮喘住院成人患者的疗效相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验